[1]Nasim F, Sabath BF, Eapen GA. Lung cancer[J]. Med Clin North Am, 2019, 103: 463-473. [2]Wood SL, Pernemalm M, Crosbie PA, et al. Molecular histology of lung cancer: from targets to treatments[J]. Cancer Treat Rev, 2015, 41: 361-375. [3]Yan Z, Lai Z, Lin J. Anticancer properties of traditional chinese Medicine[J]. Comb Chem High Throughput Screen, 2017, 20: 423-429. [4]Girisa S, Shabnam B, Monisha J, et al. Potential of zerumbone as an anti-Cancer agent[J]. Molecules, 2019, 24: 734-744. [5]王梅林, 牛精铃, 高杨, 等. 花姜酮对MCF7细胞的增殖和迁移与侵袭的影响及其作用机制研究[J]. 中国临床药理学杂志, 2018, 34: 1975-1977+2000. [6]Ma S, Lei Y, Zhang L, et al. Effects of zerumbone on proliferation and apoptosis of esophageal cancer cells and on P53 and Bcl-2 expression levels[J]. Oncol Lett, 2018, 16: 4379-4383. [7]Lv T, Zhang W, Han X. Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway[J]. Oncol Lett, 2018, 15: 7603-7610. [8]Chiang PK, Tsai WK, Chen M, et al. Zerumbone regulates DNA repair responding to ionizing radiation and enhances radiosensitivity of human prostatic cancer cells[J]. Integr Cancer Ther, 2018, 17: 292-298. [9]Kang CG, Lee HJ, Kim SH, et al. Zerumbone suppresses osteopontin-induced cell invasion through inhibiting the FAK/AKT/ROCK pathway in human non-small cell lung cancer A549 Cells[J]. J Nat Prod, 2016, 79: 156-160. [10]Liu B, Li X, Sun F, et al. HP-CagA+ regulates the expression of CDK4/CyclinD1 via reg3 to change cell cycle and promote cell proliferation[J]. Int J Mol Sci, 2019, 21: 224-234. [11]Yang Z, Li K, Liang Q, et al. Elevated hydrostatic pressure promotes ameloblastoma cell invasion through upregulation of MMP-2 and MMP-9 expression via Wnt/β-catenin signalling[J]. J Oral Pathol Med, 2018, 47: 836-846. [12]Xiao Y, Yin C, Wang Y, et al. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy[J]. Mol Oncol, 2018, 12: 883-895. [13]Xiao G, Li Y, Wang M, et al. FBXW7 suppresses epithelial-mesenchymal transition and chemo-resistance of non-small-cell lung cancer cells by targeting snai1 for ubiquitin-dependent degradation[J]. Cell Prolif, 2018, 51: e12473. doi: 10.1111/cpr.12473. [14]杜宁, 王培礼, 王猛, 等. FBXW7调控非小细胞肺癌上皮间质转化的作用机制[J]. 现代肿瘤医学, 2019, 27: 2839-2843. |